Influenza Diagnostic Market Trends Support A 7.8% CAGR Outlook Through The Forecast Period

The influenza diagnostic sector is on a promising growth trajectory as the demand for precise and rapid flu detection methods increases globally. This market is evolving rapidly due to technological advancements and rising awareness about influenza prevention and control. Below, we explore the market size, key players, current trends, and segmentation that define this expanding industry.

Influenza Diagnostic Market Size and Growth Outlook
The influenza diagnostic market is projected to reach a value of $4.19 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.8%. This expansion is driven by factors such as the increasing frequency of influenza outbreaks, heightened need for accurate molecular diagnostics, broader availability of point-of-care testing, and enhanced public health preparedness programs. Additionally, innovations in rapid diagnostic assays contribute significantly to market growth. Key trends shaping this sector include a surge in rapid influenza testing demand, wider adoption of molecular diagnostic techniques, growing preference for point-of-care testing, amplified seasonal and pandemic surveillance efforts, and continuous improvements in test accuracy and sensitivity.

The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.87 billion in 2025 to $3.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to seasonal influenza outbreaks, widespread use of rapid antigen tests, growth of hospital laboratory infrastructure, government influenza surveillance programs, increased awareness of early flu diagnosis.

Download a free sample of the influenza diagnostic market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Corporations Influencing the Influenza Diagnostic Market
The market features several prominent companies actively shaping its direction. Top players include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton dic*kinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology Inc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., and Labcorp Employer Services Inc.

Significant Acquisition Boosting Market Presence
In February 2024, Thyrocare Technologies Limited, a healthcare company based in India, acquired Think Health Diagnostic Private Limited, though the transaction amount was not disclosed. This acquisition broadens Thyrocare's service portfolio, enhancing its reach and strengthening its position within the diagnostics market. By integrating at-home ECG testing alongside blood diagnostics, Thyrocare aims to offer a comprehensive solution for premade and routine health checkups. Think Health Diagnostic specializes in home healthcare services, including telehealth, laboratory testing, and pharmacy services in India.

View the full influenza diagnostic market report:
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Current Innovations and Trends in Influenza Diagnostics
Leading firms in the market are focusing on developing cutting-edge products such as the Lucira COVID-19 & Flu Home Test, which allows rapid, simultaneous qualitative detection of influenza and COVID-19 viruses. This single-use, at-home test kit delivers results from self-collected nasal swabs in approximately 30 minutes. For example, in February 2023, Pfizer Inc., a US pharmaceutical giant, secured approval for this product. The test effectively detects influenza types A and B as well as SARS-CoV-2, facilitating timely diagnosis and management.

Segment Breakdown and Market Forecast in Global Influenza Diagnostics
This report categorizes the influenza diagnostic market into several segments:

1) Traditional Diagnostic Tests:
- Rapid Influenza Diagnostic Tests (RIDT)
- Viral Culture
- Direct Fluorescent Antibody (DFA)
- Serological Assays
- Other Traditional Diagnostic Tests

2) Molecular Diagnostic Tests:
- Reverse Transcription Polymerase Chain Reaction (RT-PCR)
- Isothermal Nucleic Acid Amplification Tests (INAAT)
- Loop Mediated Isothermal Amplification (LAMP) Assays
- Transcription Mediated Isothermal Amplification (TMA) Assays
- Other Isothermal Nucleic Acid Amplification Tests
- Other Molecular Diagnostic Methods

3) End Users:
- Hospitals and Clinical Laboratories
- Diagnostic Reference Laboratories
- Academic and Research Institutes
- Other End Users

Further subsegments include:

- For Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)
- For Viral Culture: Cell Culture, Egg-based Culture
- For Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay
- Other Traditional Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

This detailed segmentation highlights the comprehensive nature of diagnostic approaches, reflecting the diverse technologies and end users supporting the influenza diagnostic market's growth and innovation.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.